Search the Newsreel

Mobia Medical, Inc. - Common Stock MOBI

Mobia Medical, Inc. (NASDAQ:MOBI) reported strong second-quarter results with revenue reaching $13.5 million, marking a 102% increase year-over-year. This growth is attributed to the expanded adoption of its Vivistim paired vagus nerve stimulation therapy within stroke-care programs.

Armistice Capital reports 9.99% ownership of Tenon Medical (TNON) through Master Fund

Armistice Capital, LLC and Steven Boyd have reported a 9.99% beneficial ownership stake in Tenon Medical, Inc. (TNON) through Armistice Capital Master Fund Ltd. This ownership, totaling 54,554 shares, grants them shared voting and dispositive power. The filing specifies that the Master Fund retains …

Woodline Partners discloses 8.1% CalciMedica (CALC) stake and sole voting power

Woodline Partners LP has reported a beneficial ownership of 8.1% in CalciMedica, Inc., totaling 2,489,729 shares of common stock. The investment firm, acting as an adviser to Woodline Master Fund LP, holds sole voting and dispositive power over these shares. This disclosure, made via …

Armistice Capital (TMCI) discloses 6.36M-share Treace Medical ownership stake

Armistice Capital, LLC and Steven Boyd have reported a beneficial ownership stake of 6,364,000 shares in Treace Medical Concepts, Inc. (TMCI), representing 9.79% of the outstanding common stock. This ownership is held directly by Armistice Capital Master Fund Ltd., with Armistice Capital serving as …

Armistice Capital (ICCM) reports 300,332 IceCure Medical shares under shared control

Armistice Capital, LLC and Steven Boyd have reported beneficial ownership of 300,332 ordinary shares of IceCure Medical Ltd. (ICCM), representing 9.99% of the class, through a Schedule 13G SEC filing. These shares are held with shared voting and dispositive power. Armistice Capital acts as …

Why Medicenna Therapeutics Corp stock is skyrocketing today

T. Rowe Price Associates (KMTS) discloses 4.97M Kestra Medical shares in 13G/A

T. Rowe Price Associates, Inc. has disclosed a beneficial ownership of 4,968,900 shares of Kestra Medical Technologies common stock, representing 8.5% of the class as of June 30, 2026. The firm holds sole voting power over 4,966,936 shares and sole dispositive power over all …

Fresenius Medical Care stock steadies around $23 as investors weigh recent buybacks and guidance

Fresenius Medical Care stock is trading steadily around $23 in mid-August 2026, influenced by recent share buybacks and a modest year-to-date decline. The company's capital allocation strategy now includes renewed willingness for buybacks, alongside guidance for continued mid-single-digit revenue growth and improved operating income …

Armistice Capital (CALC) discloses 3.41M-share, 9.99% holding in CalciMedica

Armistice Capital, LLC and Steven Boyd have reported a significant holding in CalciMedica, Inc., disclosing beneficial ownership of 3,411,361 shares, which represents 9.99% of the company's common stock. The shares are directly held by Armistice Capital Master Fund Ltd., with Armistice Capital serving as …

New Ray Medicine Sets August Board Meeting to Review Interim Results and Dividend

SBC Medical Group's (SBC) Buy Rating Reiterated at BTIG Research

BTIG Research has reiterated its "Buy" rating for SBC Medical Group (NASDAQ: SBC) and set an $8.00 price target, representing a potential 150.78% upside. Despite this, analyst sentiment is mixed with an average "Hold" rating and an $8.50 target price from multiple analysts. The …

Medicamen Biotech Q1 Results: Net profit up 54% YoY to ₹252.69 lakh

Tian An Medicare Limited Reports Earnings Results for the Half Year Ended June 30, 2026

Insilico Medicine Introduces Biological Age into Virtual Cell Research: Launches Virtual Aging Cell Webpage and Previews Multi-Agent Driven VAC Generation Platform

Following a decade of exploration from the 2014 NVIDIA GTC to the PreciousGPT model series, Insilico Medicine presents the industry's first multi-agent Virtual Aging Cell (VAC) platform with biological age as a core condition. CAMBRIDGE, Mass., Aug. 14, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", …

Everest Medicines Reshapes Board With Director Resignation and New Appointment

Medicamen Biotech consolidated net profit declines 1.40% in the June 2026 quarter

Q3 EPS Estimates for Journey Medical Cut by HC Wainwright

Kingworld Medicines Schedules Board Meeting to Review Interim Results and Dividend

Medical Properties Trust, Inc. (NYSE:MPT) Declares $0.09 Quarterly Dividend

Sumitomo Mitsui Trust Group Inc. Acquires Shares of 534,803 Medical Properties Trust, Inc. $MPT

OrbusNeich (SEHK:6929) Stock Catches Eyes As Margin Softening Meets Profit Growth

AMS secures shareholder support for planned sale to H.B. Fuller

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Dive Brief: Advanced Medical Solutions Group's shareholders have approved the planned sale of the company to H.B. Fuller for 715 million pounds. …

Beijing Tong Ren Tang Chinese Medicine Sets Board Meeting to Approve Interim Results and Consider Dividend

Everest Medicines Sets Out Board Structure and Key Governance Committees

BeOne Medicines Sets Audit Committee Review for Dual-Market Interim Results

Diversify Wealth Management LLC Makes New $1.53 Million Investment in Medical Properties Trust, Inc. $MPT

Zhejiang Taimei Schedules Board Meeting to Approve Interim Results and Mull Dividend

Genertec Universal Medical Subsidiary to Issue Second Tranche of RMB Medium-Term Notes

Journey Medical (FBIO) Q2 2026 Earnings Call: Revenue Rises 23% as Emrosi Accelerates

Journey Medical (FBIO) reported a 23% year-over-year revenue increase to $18.5 million in Q2 2026, primarily driven by strong performance from its rosacea product, Emrosi, which generated $8.1 million in net revenue and saw a 20% sequential rise in prescriptions. The company achieved positive …

Avita Medical Stock Price Forecast. Should You Buy AVH.AX?

Utah Medical Products (NASDAQ:UTMD) Shares Pass Above 200 Day Moving Average - Time to Sell?

Utah Medical Products (NASDAQ:UTMD) shares have risen above their 200-day moving average, reaching $72.37 against an average of $66.51. The company reported quarterly earnings of $0.84 per share on $8.53 million in revenue and declared a $0.31 quarterly dividend, equivalent to a 1.7% annual …

Asset Management One Co. Ltd. Purchases New Position in Medical Properties Trust, Inc. $MPT

Asset Management One Co. Ltd. has acquired a new stake in Medical Properties Trust, Inc. (NYSE:MPT), purchasing 699,754 shares valued at approximately $3.23 million. This new position represents a 0.12% ownership in the company. Medical Properties Trust recently reported quarterly EPS of $0.15 and …

Profound Medical Corp. Share Price Live Today – NASDAQ:PROF Stock Price, Chart, News, History

Penthrox powers Medical Developments International (ASX:MVP) back to positive cash flow as paediatric approvals land

Strata critical medical director Reginald Love disposes of $29,273 in stock

Reginald Love, a director at Strata Critical Medical (NASDAQ:SRTA), sold 5,091 shares of the company's Class A common stock for a total of $29,273 on August 10, 2026. Following this transaction, Love still directly holds 146,481 shares. The company's stock has seen significant gains …

Nova Eye Medical (ASX:EYE)Turns the Corner on Profit as US Glaucoma Sales Surge